This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finegold, S. M.
Right arrow Articles by Wexler, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finegold, S. M.
Right arrow Articles by Wexler, H. M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2002, p. 2716-2719, Vol. 46, No. 8
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.8.2716-2719.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Activities of ABT-773 against Microaerophilic and Fastidious Organisms

Sydney M. Finegold,1,2,3* Denise Molitoris,4 V. T. Phan,4 M.-L. Vaisanen,4 and Hannah M. Wexler2,4

Infectious Diseases Section,1 Research Service, VA Greater Los Angeles Healthcare System, West Los Angeles Division, Los Angeles, California 90073,4 Departments of Medicine,2 Microbiology, Immunology and Molecular Genetics, UCLA School of Medicine, Los Angeles, California 900243

Received 25 June 2001/ Returned for modification 29 November 2001/ Accepted 17 April 2002

ABT-773 was tested against 317 fastidious isolates; it inhibited 99% of organisms at a concentration of 4.0 µg/ml. With ampicillin-sulbactam and levofloxacin, only 2 and 6% of these strains, respectively, were resistant at the breakpoint. With clindamycin, penicillin G, and metronidazole, 22, 26, and 58% of the strains, respectively, were resistant.


* Corresponding author. Mailing address: Infectious Diseases Section (111 F), Greater Los Angeles Healthcare System, W. L. A., Los Angeles, CA 90073. Phone: (310) 268-3678. Fax: (310) 472-7097. E-mail: sidfinegol{at}aol.com.


Antimicrobial Agents and Chemotherapy, August 2002, p. 2716-2719, Vol. 46, No. 8
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.8.2716-2719.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Garcia, I., Pascual, A., Ballesta, S., del Castillo, C., Perea, E. J. (2003). Accumulation and activity of cethromycin (ABT-773) within human polymorphonuclear leucocytes. J Antimicrob Chemother 52: 24-28 [Abstract] [Full Text]